skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Global transcriptional regulatory network for Escherichia coli robustly connects gene expression to transcription factor activities

Authors:
; ; ; ; ; ORCiD logo; ; ; ;
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1378781
Grant/Contract Number:
SC0008701
Resource Type:
Journal Article: Published Article
Journal Name:
Proceedings of the National Academy of Sciences of the United States of America
Additional Journal Information:
Journal Volume: 114; Journal Issue: 38; Related Information: CHORUS Timestamp: 2017-11-28 13:42:38; Journal ID: ISSN 0027-8424
Publisher:
Proceedings of the National Academy of Sciences
Country of Publication:
United States
Language:
English

Citation Formats

Fang, Xin, Sastry, Anand, Mih, Nathan, Kim, Donghyuk, Tan, Justin, Yurkovich, James T., Lloyd, Colton J., Gao, Ye, Yang, Laurence, and Palsson, Bernhard O. Global transcriptional regulatory network for Escherichia coli robustly connects gene expression to transcription factor activities. United States: N. p., 2017. Web. doi:10.1073/pnas.1702581114.
Fang, Xin, Sastry, Anand, Mih, Nathan, Kim, Donghyuk, Tan, Justin, Yurkovich, James T., Lloyd, Colton J., Gao, Ye, Yang, Laurence, & Palsson, Bernhard O. Global transcriptional regulatory network for Escherichia coli robustly connects gene expression to transcription factor activities. United States. doi:10.1073/pnas.1702581114.
Fang, Xin, Sastry, Anand, Mih, Nathan, Kim, Donghyuk, Tan, Justin, Yurkovich, James T., Lloyd, Colton J., Gao, Ye, Yang, Laurence, and Palsson, Bernhard O. 2017. "Global transcriptional regulatory network for Escherichia coli robustly connects gene expression to transcription factor activities". United States. doi:10.1073/pnas.1702581114.
@article{osti_1378781,
title = {Global transcriptional regulatory network for Escherichia coli robustly connects gene expression to transcription factor activities},
author = {Fang, Xin and Sastry, Anand and Mih, Nathan and Kim, Donghyuk and Tan, Justin and Yurkovich, James T. and Lloyd, Colton J. and Gao, Ye and Yang, Laurence and Palsson, Bernhard O.},
abstractNote = {},
doi = {10.1073/pnas.1702581114},
journal = {Proceedings of the National Academy of Sciences of the United States of America},
number = 38,
volume = 114,
place = {United States},
year = 2017,
month = 9
}

Journal Article:
Free Publicly Available Full Text
This content will become publicly available on March 19, 2018
Publisher's Version of Record

Save / Share:
  • Highlights: Black-Right-Pointing-Pointer Survivin inhibits the expression of p21 protein, mRNA and promoter activity. Black-Right-Pointing-Pointer Survivin neutralizes p53-induced p21 expression and promoter activity. Black-Right-Pointing-Pointer Survivin physically interacts with p53 in cancer cells. Black-Right-Pointing-Pointer Genetic silencing of endogenous survivin upregulates p21 in p53 wild type cancer cells. Black-Right-Pointing-Pointer Both p53 and survivin interacts on the two p53-binding sites in the p21 promoter. -- Abstract: Growing evidence suggests a role for the antiapoptotic protein survivin in promotion of cancer cell G1/S transition and proliferation. However, the underlying mechanism is unclear. Further, although upregulation of p21{sup WAF1/CIP1} by p53 plays an important role inmore » p53-mediated cell G1 arrests in response to various distresses, it is unknown whether survivin plays a role in the regulation of p21{sup WAF1/CIP1} expression. Here, we report that exogenous expression of survivin in p53-wild type MCF-7 breast cancer cells inhibits the expression of p21{sup WAF1/CIP1} protein, mRNA and promoter activity, while the survivin C84A mutant and antisense failed to do so. Cotransfection experiments in the p53 mutant H1650 lung cancer cell line showed that survivin neutralizes p53-induced p21{sup WAF1/CIP1} expression and promoter activity. Importantly, genetically silencing of endogenous survivin using lentiviral survivin shRNA also enhances endogenous p21 in p53 wild type cancer cells, suggesting the physiological relevance of the fining. We further demonstrated that both p53 and survivin interacts on the two p53-binding sites in the p21{sup WAF1/CIP1} promoter (-2313 to -2212; -1452 to -1310), and survivin physically interacts with p53 in cancer cells. Together, we propose that survivin may act as a transcription factor or cofactor to interact with p53 on the p21{sup WAF1/CIP1} promoter leading to the inhibition of p21{sup WAF1/CIP1} expression at least in part by neutralizing p53-mediated transcriptional activation of the p21 gene.« less
  • The Escherichia coli uvrB gene, located on a 1.5-megadalton EcoRI fragment F, derived from transducing phage lambda b2att/sup 2/ (lambda b2cI857intam6..delta..(bioAB)bioFCD+uvrB+), has been cloned in the unique EcoRI site of several relaxed plasmids, i.e., pMB9, pBR322, and pBH20 (=pBR322, including the lac regulatory elements). Expression of the uvrB gene, both on pMB9 and on pBH20, occurs only when fragment F has one particular orientation. Cloning of this fragment on pBR322 in either orientation does not allow expression of the uvrB gene. Transcription of this gene on pNP5 (=pMB9 uvrB) is shown to be dependent on a pMB9 promotor that ismore » located on a 0.22-megadalton EcoRI-HindIII fragment. Using plasmid pBH20 as a vector, we could demonstrate that expression of the uvrB gene is under control of the lac promotor-operator region. From deoxyribonucleic acid-deoxyribonucleic acid hybridization experiments with lambda pgal8 deoxyribonucleic acid and restriction fragments of pNP5 deoxyribonucleic acid it could be shown that the uvrB gene is transcribed clockwise on the chromosome.« less
  • A human B-cell growth factor (BCGF) (12 kilodaltons) supports the clonal proliferation of B lymphocytes. A clone was isolated that contained the proper structural sequence to encode biologically active, 12-kilodalton BCGF in Escherichia coli and to hybridize to a specific messenger RNA, identified by in vitro translation in Xenopus laevis oocytes. A relatively hydrophobic region of 18 amino acids was found at the amino terminal of the 124 - amino acid - long polypeptide. The carboxyl terminal is composed of at least 32 amino acids that are derived from nucleotide sequences bearing significant homology to the Alu repeat family.
  • Lung cancer is the leading cause of cancer-mediated death. Although various therapeutic approaches are used for lung cancer treatment, these mainly target the tumor suppressor p53 transcription factor, which is involved in apoptosis and cell cycle arrest. However, p53-targeted therapies have limited application in lung cancer, since p53 is found to be mutated in more than half of lung cancers. In this study, we propose tumor suppressor FOXA2 as an alternative target protein for therapies against lung cancer and reveal a possible FOXA2-centered transcriptional regulation network by identifying new target genes and binding partners of FOXA2 by using various screeningmore » techniques. The genes encoding Glu/Asp-rich carboxy-terminal domain 2 (CITED2), nuclear receptor subfamily 0, group B, member 2 (NR0B2), cell adhesion molecule 1 (CADM1) and BCL2-associated X protein (BAX) were identified as putative target genes of FOXA2. Additionally, the proteins including highly similar to heat shock protein HSP 90-beta (HSP90A), heat shock 70 kDa protein 1A variant (HSPA1A), histone deacetylase 1 (HDAC1) and HDAC3 were identified as novel interacting partners of FOXA2. Moreover, we showed that FOXA2-dependent promoter activation of BAX and p21 genes is significantly reduced via physical interactions between the identified binding partners and FOXA2. These results provide opportunities to understand the FOXA2-centered transcriptional regulation network and novel therapeutic targets to modulate this network in p53-deficient lung cancer. - Highlights: • Identification of new target genes of FOXA2. • Identifications of novel interaction proteins of FOXA2. • Construction of FOXA2-centered transcriptional regulatory network in non-small cell lung cancer.« less